Source: Medicines & Healthcare Products Regulatory Agency (GB) | Revision Year: 2012 | Publisher: Sanofi-aventis One Onslow Street Guildford Surrey, GU1 4YS UK
Clexane Syringes.
Solution for injection.
Clear, colourless to pale yellow solution.
20 mg Injection: Enoxaparin sodium 20 mg (equivalent to 2,000 IU anti-Xa activity) in 0.2 mL Water for Injections
40 mg Injection: Enoxaparin sodium 40 mg (equivalent to 4,000 IU anti-Xa activity) in 0.4 mL Water for Injections
60 mg Injection: Enoxaparin sodium 60 mg (equivalent to 6,000 IU anti-Xa activity) in 0.6 mL Water for Injections
80 mg Injection: Enoxaparin sodium 80 mg (equivalent to 8,000 IU anti-Xa activity) in 0.8 mL Water for Injections
100 mg Injection: Enoxaparin sodium 100mg (equivalent to 10,000 IU anti-Xa activity) in 1.0 mL Water for Injections
For full list of excipients, see section 6.1
Water for Injections
Solution for injection in Type I glass pre-filled syringes fitted with injection needle and an automatic safety device in packs of 10.
Sanofi-aventis
One Onslow Street
Guildford
Surrey, GU1 4YS
UK
PL 04425/0187
Date of first authorisation: 22 October 1990
Date of latest renewal: 8 August 2002
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.